title: Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention.
abstract: BACKGROUND
  Postconditioning has been shown to reduce infarct size during reperfusion (< 72 hours). However, it is unknown whether the infarct size reduction with postconditioning is a long-term effect after clinical percutaneous coronary intervention (PCI). The present study tested the hypothesis that postconditioning during primary PCI preserves global cardiac function and reduces infarct size in patients after prolonged reperfusion.
  
  
  METHODS
  Fortyone patients undergoing PCI were randomly assigned to a control (n = 18) or postconditioning (n = 23) group within 90 minutes after admission. After predilatation, in the Control group, no intervention was applied in the first 3 minutes of reperfusion, while in the Postconditioning group, three cycles of 30-second angioplasty balloon deflation and 30-second inflation were repetitively applied.
  
  
  RESULTS
  There was a trend toward increased ejection fraction quantified by echocardiography in the Postconditioning group compared to that in the Control group (54 +/- 12.9% vs. 44 +/- 16.7%; p > 0.05). Infarct size represented by the area under the curve of creatine-kinase activity during the first 72 hours of reperfusion was significantly less by 27% in the Postconditioning group than that in the Control group (58,002 +/- 593 vs. 79,787 +/- 681; p = 0.04). After 7 days of reperfusion, infarct size quantified by single-photon emission computed tomography was 27% smaller in the Postconditioning group than that measured in the Control group (31.3 +/- 8.6% vs. 22.8 +/- 6.7% of left ventricle; p < 0.05).
  
  
  CONCLUSIONS
  This study demonstrates that postconditioning following PCI significantly protects the heart against ischemia/reperfusion-induced injury. More importantly, this study indicates that protection with postconditioning is still apparent 1 week following reperfusion, suggesting long-term protection.
authors: Department of Cardiology, Beijing Chaoyang Hospital of Capital University of Medical Science, No. 8 Baijiazhuang Road Chaoyang District, Beijing, China, 100020. yangxc@medmail.com.cn
authors: Xin-Chun
authors: XC
authors: Yang
authors: Yu
authors: Y
authors: Liu
authors: Le-Feng
authors: LF
authors: Wang
authors: Liang
authors: L
authors: Cui
authors: Tie
authors: T
authors: Wang
authors: Yong-Gui
authors: YG
authors: Ge
authors: Hong-Shi
authors: HS
authors: Wang
authors: Wei-Ming
authors: WM
authors: Li
authors: Li
authors: L
authors: Xu
authors: Zhu-Hua
authors: ZH
authors: Ni
authors: Sheng-Hui
authors: SH
authors: Liu
authors: Lin
authors: L
authors: Zhang
authors: Hui-Min
authors: HM
authors: Jia
authors: Jakob
authors: J
authors: Vinten-Johansen
authors: Zhi-Qing
authors: ZQ
authors: Zhao
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D001794:Blood Pressure; D017023:Coronary Angiography; D003326:Coronary Circulation; D003402:Creatine Kinase / Q000097:blood; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000628:therapy*; D015428:Myocardial Reperfusion Injury / Q000175:diagnosis* / Q000517:prevention & control*; D013318:Stroke Volume; D015899:Tomography, Emission-Computed, Single-Photon; D016896:Treatment Outcome; D016277:Ventricular Function, Left
chemical_list: D003402:Creatine Kinase